Vita Coco Company, Inc.·4

Apr 17, 4:34 PM ET

Roper Martin 4

4 · Vita Coco Company, Inc. · Filed Apr 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Vita Coco (COCO) CEO Roper Martin Exercises Options, Sells 25,000 Shares

What Happened

  • Roper Martin, CEO of Vita Coco Company, exercised 25,000 stock options at $10.18 per share (cost $254,450) on April 16, 2026, and immediately sold 25,000 shares in an open-market transaction at $50.00 per share for proceeds of $1,250,000. The filing also reports a separate derivative conversion of 25,000 shares shown as a disposition at $0 consideration (no cash proceeds stated).
  • The primary economic effect reported was a sale of 25,000 shares (disposition), while the option exercise provided the shares that were sold.

Key Details

  • Transaction date: 2026-04-16; Sale price: $50.00 x 25,000 = $1,250,000; Exercise price: $10.18 x 25,000 = $254,450.
  • Sales were effected pursuant to a Rule 10b5-1 trading plan (footnote F1).
  • Filing was submitted 2026-04-17 for transactions on 2026-04-16 (timely reporting).
  • The filing also lists a derivative conversion/disposition of 25,000 shares at $0 (no cash reported); the filing does not specify the reason or destination for those shares.
  • Additional footnotes in the filing reference family trusts (F2–F4) and various option vesting schedules (F5–F9); the excerpt provided does not state the insider’s post-transaction beneficial ownership.

Context

  • This sequence (exercise of options followed by an immediate sale) is commonly a cashless realization of option value: the holder pays the strike to obtain shares and sells them at market price, capturing the spread.
  • Sales under a pre-established 10b5-1 plan are routine and do not, by themselves, indicate the insider’s view of the company’s long-term prospects.
  • No purchase (bullish) transaction was reported; the filing is primarily a sale/realization event.

Insider Transaction Report

Form 4
Period: 2026-04-16
Roper Martin
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-16$10.18/sh+25,000$254,450323,484 total
  • Sale

    Common Stock

    [F1]
    2026-04-16$50.00/sh25,000$1,250,000298,484 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F5]
    2026-04-1625,000425,214 total
    Exercise: $10.18Exp: 2029-09-19Common Stock (25,000 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: by Chris Roper FT)
    215,631
  • Common Stock

    [F3]
    (indirect: by Peter Roper FT)
    216,131
  • Common Stock

    [F4]
    (indirect: by Thomas Roper FT)
    216,131
  • Common Stock

    (indirect: By Spouse)
    41,200
  • Non-Qualified Stock Option (Right to Buy)

    [F5]
    Exercise: $10.18Exp: 2031-01-11Common Stock (40,950 underlying)
    40,950
  • Non-Qualified Stock Option (Right to Buy)

    [F6]
    Exercise: $15.00Exp: 2031-10-21Common Stock (298,507 underlying)
    298,507
  • Non-Qualified Stock Option (Right to Buy)

    [F7]
    Exercise: $16.91Exp: 2033-03-10Common Stock (46,875 underlying)
    46,875
  • Non-Qualified Stock Option (Right to Buy)

    [F5]
    Exercise: $16.91Exp: 2033-03-10Common Stock (185,133 underlying)
    185,133
  • Non-Qualified Stock Option (Right to Buy)

    [F8]
    Exercise: $26.18Exp: 2034-03-04Common Stock (62,743 underlying)
    62,743
  • Non-Qualified Stock Option (Right to Buy)

    [F9]
    Exercise: $32.78Exp: 2035-03-03Common Stock (70,715 underlying)
    70,715
Footnotes (9)
  • [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]These shares are held by the Christopher G. Roper Exempt Family Trust.
  • [F3]These shares are held by the Peter S. Roper Exempt Family Trust.
  • [F4]These shares are held by the Thomas L. Roper Exempt Family Trust.
  • [F5]The stock option is fully vested and currently exercisable.
  • [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.
  • [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
  • [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
  • [F9]The stock option vests in four equal annual installments beginning on March 3, 2026.
Signature
/s/ Alison Klein, attorney-in-fact for Martin Roper|2026-04-17

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT